BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31843141)

  • 1. XPC beyond nucleotide excision repair and skin cancers.
    Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
    Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.
    Nasrallah A; Fayyad N; Kobaisi F; Badran B; Fayyad-Kazan H; Fayyad-Kazan M; Sève M; Rachidi W
    Oxid Med Cell Longev; 2021; 2021():6689403. PubMed ID: 34630850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions.
    Meira LB; Reis AM; Cheo DL; Nahari D; Burns DK; Friedberg EC
    Mutat Res; 2001 Jun; 477(1-2):51-8. PubMed ID: 11376686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.
    Melis JP; Kuiper RV; Zwart E; Robinson J; Pennings JL; van Oostrom CT; Luijten M; van Steeg H
    DNA Repair (Amst); 2013 Dec; 12(12):1081-6. PubMed ID: 24084170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.
    Nasrallah NA; Wiese BM; Sears CR
    Front Oncol; 2022; 12():846965. PubMed ID: 35530314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair.
    Sugasawa K; Ng JM; Masutani C; Iwai S; van der Spek PJ; Eker AP; Hanaoka F; Bootsma D; Hoeijmakers JH
    Mol Cell; 1998 Aug; 2(2):223-32. PubMed ID: 9734359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C.
    Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative DNA damage and nucleotide excision repair.
    Melis JP; van Steeg H; Luijten M
    Antioxid Redox Signal; 2013 Jun; 18(18):2409-19. PubMed ID: 23216312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.
    Khan SG; Oh KS; Emmert S; Imoto K; Tamura D; Digiovanna JJ; Shahlavi T; Armstrong N; Baker CC; Neuburg M; Zalewski C; Brewer C; Wiggs E; Schiffmann R; Kraemer KH
    DNA Repair (Amst); 2009 Jan; 8(1):114-25. PubMed ID: 18955168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of XPC: implications in cancer and oxidative DNA damage.
    Melis JP; Luijten M; Mullenders LH; van Steeg H
    Mutat Res; 2011; 728(3):107-17. PubMed ID: 21763452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
    Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
    PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC.
    Bernardes de Jesus BM; Bjørås M; Coin F; Egly JM
    Mol Cell Biol; 2008 Dec; 28(23):7225-35. PubMed ID: 18809580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interactions between XPC and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer.
    Cheo DL; Meira LB; Hammer RE; Burns DK; Doughty AT; Friedberg EC
    Curr Biol; 1996 Dec; 6(12):1691-4. PubMed ID: 8994835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.
    Khan SG; Yamanegi K; Zheng ZM; Boyle J; Imoto K; Oh KS; Baker CC; Gozukara E; Metin A; Kraemer KH
    Hum Mutat; 2010 Feb; 31(2):167-75. PubMed ID: 19953607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema.
    Berg RJ; Ruven HJ; Sands AT; de Gruijl FR; Mullenders LH
    J Invest Dermatol; 1998 Apr; 110(4):405-9. PubMed ID: 9540983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum group C sensor: unprecedented recognition strategy and tight spatiotemporal regulation.
    Puumalainen MR; Rüthemann P; Min JH; Naegeli H
    Cell Mol Life Sci; 2016 Feb; 73(3):547-66. PubMed ID: 26521083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
    Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
    J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.